- Home
- Publications
- Publication Search
- Publication Details
Title
Basal/HER2 breast carcinomas
Authors
Keywords
-
Journal
CELL CYCLE
Volume 12, Issue 2, Pages 225-245
Publisher
Informa UK Limited
Online
2013-01-15
DOI
10.4161/cc.23274
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin: Multi-faceted protection against cancer
- (2015) Sonia Del Barco et al. Oncotarget
- Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
- (2015) Sílvia Cufí et al. Oncotarget
- Krüppel-like Factor 4 Inhibits Tumorigenic Progression and Metastasis in a Mouse Model of Breast Cancer
- (2015) Jennifer L Yori et al. NEOPLASIA
- Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
- (2012) Karthika Natarajan et al. BIOCHEMICAL PHARMACOLOGY
- Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin)
- (2012) Cristina Oliveras-Ferraros et al. CELL CYCLE
- Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells
- (2012) A Papi et al. CELL DEATH AND DIFFERENTIATION
- Cancer Stem Cells: Current Status and Evolving Complexities
- (2012) Jane E. Visvader et al. Cell Stem Cell
- Identification and characterization of cancer initiating cells from BRCA1 related mammary tumors using markers for normal mammary stem cells
- (2012) Athanassios Vassilopoulos et al. International Journal of Biological Sciences
- Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2-positive cancer cells and cancer stem cells
- (2012) Prajakta S. Oak et al. INTERNATIONAL JOURNAL OF CANCER
- Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells
- (2012) Toni Celià-Terrassa et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer Stem Cell Hypothesis and Trastuzumab in HER2-Negative Tumors
- (2012) R. S. Tuma JNCI-Journal of the National Cancer Institute
- Epithelial-Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer
- (2012) A. Giordano et al. MOLECULAR CANCER THERAPEUTICS
- Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population
- (2012) Hasan Korkaya et al. MOLECULAR CELL
- Reprogramming cancer cells: back to the future
- (2012) J-Y Lang et al. ONCOGENE
- Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming
- (2012) X Zhang et al. ONCOGENE
- Anti-Tumor Effect against Human Cancer Xenografts by a Fully Human Monoclonal Antibody to a Variant 8-Epitope of CD44R1 Expressed on Cancer Stem Cells
- (2012) Kazue Masuko et al. PLoS One
- TIMP-1 Induces an EMT-Like Phenotypic Conversion in MDCK Cells Independent of Its MMP-Inhibitory Domain
- (2012) Young Suk Jung et al. PLoS One
- The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion
- (2012) Nina Fenouille et al. PLoS One
- Krüppel-Like Factor 4, a Tumor Suppressor in Hepatocellular Carcinoma Cells Reverts Epithelial Mesenchymal Transition by Suppressing Slug Expression
- (2012) Ze-Shiang Lin et al. PLoS One
- Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ER - breast cancer
- (2012) J. C. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- iPSCs from cancer cells: challenges and opportunities
- (2012) Verónica Ramos-Mejia et al. TRENDS IN MOLECULAR MEDICINE
- Antitumor effect of the mTOR inhibitor everolimus in combination with trastuzumab on human breast cancer stem cells in vitro and in vivo
- (2012) Yuanxi Zhu et al. TUMOR BIOLOGY
- Prognostic Value of Basal Phenotype in HER2-overexpressing Breast Cancer
- (2011) Sanjay P. Bagaria et al. ANNALS OF SURGICAL ONCOLOGY
- Inhibitor of Apoptosis (IAP) survivin is indispensable for survival of HER2 gene-amplified breast cancer cells with primary resistance to HER1/2-targeted therapies
- (2011) Cristina Oliveras-Ferraros et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo
- (2011) Dimitris Anastassiou et al. BMC CANCER
- Reprogramming of gastrointestinal cancer cells
- (2011) DyahLaksmi Dewi et al. CANCER SCIENCE
- Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
- (2011) Piyush B. Gupta et al. CELL
- The tumorigenicity of diploid and aneuploid human pluripotent stem cells
- (2011) Barak Blum et al. CELL CYCLE
- Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: Induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a
- (2011) Cristina Oliveras-Ferraros et al. CELL CYCLE
- Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer
- (2011) Nicole Vincent Jordan et al. CELL CYCLE
- Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions
- (2011) Alejandro Vazquez-Martin et al. DRUG RESISTANCE UPDATES
- E-cadherin, a new mixer in the Yamanaka cocktail
- (2011) William E Lowry EMBO REPORTS
- E-cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming
- (2011) Torben Redmer et al. EMBO REPORTS
- Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor-negative breast cancer
- (2011) Yoshimi Arima et al. INTERNATIONAL JOURNAL OF CANCER
- Snail1 controls epithelial–mesenchymal lineage commitment in focal adhesion kinase–null embryonic cells
- (2011) Xiao-Yan Li et al. JOURNAL OF CELL BIOLOGY
- Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
- (2011) S. Ricardo et al. JOURNAL OF CLINICAL PATHOLOGY
- SPARC Promotes Cathepsin B-Mediated Melanoma Invasiveness through a Collagen I/α2β1 Integrin Axis
- (2011) María R. Girotti et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Critical and Reciprocal Regulation of KLF4 and SLUG in Transforming Growth Factor -Initiated Prostate Cancer Epithelial-Mesenchymal Transition
- (2011) Y.-N. Liu et al. MOLECULAR AND CELLULAR BIOLOGY
- Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating–cancer stem cells: distinct, overlapping or same populations
- (2011) S Floor et al. ONCOGENE
- Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion
- (2011) F Yu et al. ONCOGENE
- CD10: A tool to crack the role of stem cells in breast cancer
- (2011) V. Maguer-Satta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Defining the cellular precursors to human breast cancer
- (2011) P. J. Keller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
- (2011) C. L. Chaffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Concise Review: Neutral Endopeptidase (CD10): A Multifaceted Environment Actor in Stem Cells, Physiological Mechanisms, and Cancer
- (2011) Veronique Maguer-Satta et al. STEM CELLS
- Epithelial and Mesenchymal Subpopulations Within Normal Basal Breast Cell Lines Exhibit Distinct Stem Cell/Progenitor Properties
- (2011) David Sarrio et al. STEM CELLS
- Diversification of caldesmon-linked actin cytoskeleton in cell motility
- (2011) Taira Mayanagi et al. Cell Adhesion & Migration
- Reduction of the putative CD44+CD24− breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047
- (2010) Helena Cirenajwis et al. ANTI-CANCER DRUGS
- Dynamic emergence of the mesenchymal CD44posCD24neg/low phenotype in HER2-gene amplified breast cancer cells with de novo resistance to trastuzumab (Herceptin)
- (2010) Cristina Oliveras-Ferraros et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Janus face of pluripotent stem cells - Connection between pluripotency and tumourigenicity
- (2010) Anna M. Wobus BIOESSAYS
- Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1
- (2010) Hoon Kim et al. BMC Medical Genomics
- The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells
- (2010) Alejandro Vazquez-Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- Cell Signaling by Urokinase-type Plasminogen Activator Receptor Induces Stem Cell-like Properties in Breast Cancer Cells
- (2010) M. Jo et al. CANCER RESEARCH
- Molecular biology of breast cancer stem cells: Potential clinical applications
- (2010) Nam P. Nguyen et al. CANCER TREATMENT REVIEWS
- Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis
- (2010) Sílvia Cufí et al. CELL CYCLE
- Metformin regulates breast cancer stem cello ntogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
- (2010) Alejandro Vazquez-Martin et al. CELL CYCLE
- Metformin and cancer: Doses, mechanisms and the dandelion and hormetic phenomena
- (2010) Begoña Martin-Castillo et al. CELL CYCLE
- When Fibroblasts MET iPSCs
- (2010) Jose M. Polo et al. Cell Stem Cell
- Integrin Alpha 6 Regulates Glioblastoma Stem Cells
- (2010) Justin D. Lathia et al. Cell Stem Cell
- A Mesenchymal-to-Epithelial Transition Initiates and Is Required for the Nuclear Reprogramming of Mouse Fibroblasts
- (2010) Ronghui Li et al. Cell Stem Cell
- Functional Genomics Reveals a BMP-Driven Mesenchymal-to-Epithelial Transition in the Initiation of Somatic Cell Reprogramming
- (2010) Payman Samavarchi-Tehrani et al. Cell Stem Cell
- Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
- (2010) S. Y. Park et al. CLINICAL CANCER RESEARCH
- Breast Cancer in the Personal Genomics Era
- (2010) Rachel E. Ellsworth et al. CURRENT GENOMICS
- Krüppel-like Factor 4 Inhibits Epithelial-to-Mesenchymal Transition through Regulation of E-cadherin Gene Expression
- (2010) Jennifer L. Yori et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Stem cell property epithelial-to-mesenchymal transition is a core transcriptional network for predicting cetuximab (Erbitux™) efficacy in KRAS wild-type tumor cells
- (2010) Cristina Oliveras-Ferraros et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- HER2 Signatures in Breast Cancer: Ready to Go to Print?
- (2010) Pieter J.A. Eichhorn et al. JOURNAL OF CLINICAL ONCOLOGY
- Beyond HER2 and Trastuzumab: Heterogeneity, Systems Biology, and Cancer Origin Research May Guide the Future for Personalized Treatment of Very Early but Aggressive Breast Cancer
- (2010) Dimitrios H. Roukos JOURNAL OF CLINICAL ONCOLOGY
- Future of Personalized Medicine in Oncology: A Systems Biology Approach
- (2010) Ana Maria Gonzalez-Angulo et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting Breast Cancer Stem Cells
- (2010) Suling Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of Subtypes in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome
- (2010) Johan Staaf et al. JOURNAL OF CLINICAL ONCOLOGY
- PAI-1 Mediates the TGF-β1+EGF-Induced “Scatter” Response in Transformed Human Keratinocytes
- (2010) Jennifer Freytag et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer
- (2010) Tony Blick et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapy
- (2010) Xi-wei Ding et al. LIFE SCIENCES
- Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
- (2010) Sunil Badve et al. MODERN PATHOLOGY
- Peroxisome Proliferator-Activated Receptor- Activation Inhibits Tumor Metastasis by Antagonizing Smad3-Mediated Epithelial-Mesenchymal Transition
- (2010) A. K. Reka et al. MOLECULAR CANCER THERAPEUTICS
- Deconstructing the molecular portraits of breast cancer
- (2010) Aleix Prat et al. Molecular Oncology
- Triple-negative breast cancer: disease entity or title of convenience?
- (2010) Lisa Carey et al. Nature Reviews Clinical Oncology
- The expression of activated Y-box binding protein-1 serine 102 mediates trastuzumab resistance in breast cancer cells by increasing CD44+ cells
- (2010) J Dhillon et al. ONCOGENE
- Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway
- (2010) C Deisenroth et al. ONCOGENE
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks
- (2010) D H Roukos PHARMACOGENOMICS JOURNAL
- Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
- (2010) J. H. Taube et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Physiological cellular reprogramming and cancer
- (2010) Fernando Abollo-Jiménez et al. SEMINARS IN CANCER BIOLOGY
- Cancer as a reprogramming-like disease: Implications in tumor development and treatment
- (2010) Andrés Castellanos et al. SEMINARS IN CANCER BIOLOGY
- The CD10 Enzyme Is a Key Player to Identify and Regulate Human Mammary Stem Cells
- (2010) Elodie Bachelard-Cascales et al. STEM CELLS
- E-Cadherin-Mediated Cell-Cell Contact Is Critical for Induced Pluripotent Stem Cell Generation
- (2010) Taotao Chen et al. STEM CELLS
- Systems Biology and Genomics of Breast Cancer
- (2010) C. M. Perou et al. Cold Spring Harbor Perspectives in Biology
- Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
- (2009) E. A. Rakha et al. CLINICAL CANCER RESEARCH
- Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab
- (2009) A. Magnifico et al. CLINICAL CANCER RESEARCH
- ABCG2: the key to chemoresistance in cancer stem cells?
- (2009) Yi An et al. Expert Opinion on Drug Metabolism & Toxicology
- Understanding the Mechanisms Behind Trastuzumab Therapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2009) Neil L. Spector et al. JOURNAL OF CLINICAL ONCOLOGY
- High Risk of Recurrence for Patients With Breast Cancer Who Have Human Epidermal Growth Factor Receptor 2–Positive, Node-Negative Tumors 1 cm or Smaller
- (2009) Ana M. Gonzalez-Angulo et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognosis of Women With Metastatic Breast Cancer byHER2Status and Trastuzumab Treatment: An Institutional-Based Review
- (2009) Shaheenah Dawood et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiation Resistance of Breast Cancer Stem Cells: Understanding the Clinical Framework
- (2009) Bisrat G. Debeb et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Stemming Resistance to HER-2 Targeted Therapy
- (2009) Philippe L. Bedard et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Molecular predictors of response to trastuzumab and lapatinib in breast cancer
- (2009) Francisco J. Esteva et al. Nature Reviews Clinical Oncology
- Gene-Expression Signatures in Breast Cancer
- (2009) Christos Sotiriou et al. NEW ENGLAND JOURNAL OF MEDICINE
- The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine
- (2009) J. S. Ross et al. ONCOLOGIST
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53-Mediated Mouse Mammary Tumors
- (2008) N. Shafee et al. CANCER RESEARCH
- Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
- (2008) D. Sarrio et al. CANCER RESEARCH
- Epithelial mesenchymal transition traits in human breast cancer cell lines
- (2008) T. Blick et al. CLINICAL & EXPERIMENTAL METASTASIS
- Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
- (2008) C. Desmedt et al. CLINICAL CANCER RESEARCH
- Implications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy
- (2008) Madhuri Kakarala et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis
- (2008) Christine E. Eyler et al. JOURNAL OF CLINICAL ONCOLOGY
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- HER2Status and Benefit from Adjuvant Trastuzumab in Breast Cancer
- (2008) Soonmyung Paik et al. NEW ENGLAND JOURNAL OF MEDICINE
- HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
- (2008) H Korkaya et al. ONCOGENE
- Triple-negative/basal-like breast cancer: review
- (2008) Emad A. Rakha et al. PATHOLOGY
- Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers
- (2008) N. Dumont et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pluripotent human stem cell lines: what we can learn about cancer initiation
- (2008) Tamra E. Werbowetski-Ogilvie et al. TRENDS IN MOLECULAR MEDICINE
- Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers
- (2007) Hui Liu et al. HUMAN PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search